During the past decade, Clinica 20/20 conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clinica 20/20" are "Cataract" (4 trials). Many other conditions were trialed in "Clinica 20/20" in a lesser frequency.

Most popular intervention types in "Clinica 20/20" are "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Control Eye" (2 trials), "FDA approved Intraocular Lens" (1 trials), "FDA approved Intraocular lens" (1 trials), "Gemini IV" (1 trials) and "Omega Gemini III Rev 2 Device" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinica 20/20" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Clinica 20/20". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Clinica 20/20, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinica 20/20, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".